Koji Ando

Years Active: 2018-2024
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Yuji Kobayashi, Koji Ando, Yoshitaka Imaizumi, Hikaru Sakamoto, Hideaki Kitanosono, Masataka Taguchi, Hiroyuki Mishima, Akira Kinoshita, Shara Bekytbek, Maki Baba, Takeharu Kato, Makiko Horai, Hidehiro Itonaga, Shinya Sato, Koh-Ichiro Yoshiura, Yasushi Miyazaki
RUNX1 expression is regulated by a super-enhancer and is a therapeutic target in adult T-cell leukemia/lymphoma. Leukemia & lymphoma (2024)
Hikaru Sakamoto, Koji Ando, Yoshitaka Imaizumi, Hiroyuki Mishima, Akira Kinoshita, Yuji Kobayashi, Hideaki Kitanosono, Takeharu Kato, Yasushi Sawayama, Shinya Sato, Tomoko Hata, Masahiro Nakashima, Koh-Ichiro Yoshiura, Yasushi Miyazaki
Alvocidib inhibits IRF4 expression via super-enhancer suppression and adult T-cell leukemia/lymphoma cell growth. Cancer science (2022)
Yuji Kobayashi, Koji Ando, Tomoko Hata, Yoshitaka Imaizumi, Kazuhiro Nagai, Rena Kamijyo, Takeharu Katoh, Jun Taguchi, Hidehiro Itonaga, Shinya Sato, Yasushi Sawayama, Yasushi Miyazaki
Complete remission of pure white cell aplasia associated with thymoma after thymectomy and cyclosporine administration. International journal of hematology 109 (3) (2018)

Koji Ando.css-eqlu8i{font-size:small;padding-left:4px;}